Brainstorm Cell Therapeutics Inc. – Filings and Transcripts

OTC: BCLI
Share price (6/12/26): $0.75
Market cap (6/12/26): $8.277 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

Prospectuses and Registrations Filter

Registration of securities for employees

Initial registration of new securities

Removal from listing

Registration withdrawal request

Registration of securities for employees

Ownership Filter

Pitts Peter Joe

Frenkel Jacob A

News Filter

Appoints Former FDA Associate Commissioner Peter J. Pitts to Board of Directors

Announces First Quarter 2026 Financial Results and Provides Corporate Update

Announces Full Year 2025 Financial Results and Provides Corporate Update

Material Definitive Agreement, Unregistered Sales of Equity Securities, Change in Directors, Officers or Compensation, Financial Statements or Exhibits

Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements or Exhibits

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Definitive proxy

Preliminary revised proxy

Other Filter

Notice of effectiveness

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Correspondence with the SEC